18. January 2018

A new feature of the revamped 2018 agenda is the expansion of the programme to cover advanced drug delivery devices and the areas of bioanalysis & stabilisation. Leading experts will discuss slow delivery devices for antibodies, needle-free delivery systems as well as updates in auto-injectors. The bioanalysis & stabilisation session will look at such areas as bioanalytical development for large molecules, prediction and characterisation of aggregates and particle-size analysis.